Parkinson and Alzheimer

Categories

All ArticlesAntioxidant properties / No toxicity / SafetyCancer / Transport / DeliveryLife extension / Rheumatoid arthritis / Air toxicity / Ischemia / AtherosclerosisOsteoporosis / Thrombosis / Diabetes / Heart attackParkinson and AlzheimerVarious positive properties

Amphiphilic surface chemistry of fullerenols is necessary for inhibiting the amyloid aggregation of alpha-synuclein NACore >>

Distinct Binding Dynamics, Sites and Interactions of Fullerene and Fullerenols with Amyloid-β Peptides Revealed by Molecular Dynamics Simulations >>

Preferential binding of fullerene and fullerenol with the N-terminal and middle regions of amyloid beta peptide: an in silico investigation >>

Fullerenol nanoparticles decrease ischaemia-induced brain injury and oedema through inhibition of oxidative damage and aquaporin-1 expression in ischaemic stroke >>

Fullerenol C60(OH)16 prevents amyloid fibrillization of Aβ40-in vitro and in silico approach >>

The neuroprotective effect of fullerenols on a model of Parkinson’s disease in Drosophila melanogaster >>

Back to top